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# The Author(s) 2018
Abstract
Genetic factors account for up to 80% of the liability for schizophrenia (SCZ) and bipolar disorder (BD). Genome-wide
association studies have successfully identified several genes associated with increased risk for both disorders. This has allowed
researchers to model the aggregate effect of genes associated with disease status and create a polygenic risk score (PGRS) for
each individual. The interest in imaging genetics using PGRS has grown in recent years, with several studies now published. We
have conducted a systematic review to examine the effects of PGRS of SCZ, BD and cross psychiatric disorders on brain function
and connectivity using fMRI data. Results indicate that the effect of genetic load for SCZ and BD on brain function affects task-
related recruitment, with frontal areas having amore prominent role, independent of task. Additionally, the results suggest that the
polygenic architecture of psychotic disorders is not regionally confined but impacts on the task-dependent recruitment of multiple
brain regions. Future imaging genetics studies with large samples, especially population studies, would be uniquely informative
in mapping the spatial distribution of the genetic risk to psychiatric disorders on brain processes during various cognitive tasks
and may lead to the discovery of biological pathways that could be crucial in mediating the link between genetic factors and
alterations in brain networks.
Keywords Polygenic risk score (PGRS) . Functional magnetic resonance imaging (fMRI) . Schizophrenia . Bipolar disorder .
Psychosis . Cognition
Introduction
Psychosis is a serious mental illness characterized by delu-
sions, hallucinations and disorganized thinking or behavior.
Schizophrenia (SCZ) and bipolar disorder (BD) are the two
most common psychiatric disorders associated with psychotic
symptoms. Like most complex disorders of non-Mendelian
inheritance they are the product of a combination of genetic
and environmental factors. Heritability has been calculated as
high as 80% for SCZ (Cardno et al. 1999) and 93% for BD
(Kieseppa et al. 2004). Both are polygenetic illnesses with
thousands of genetic risk factors interacting, each with low
to moderate effect (Geschwind and Flint 2015; Kerner 2015;
Lichtenstein et al. 2009). Results from genome wide associa-
tion studies (GWAS) support the idea that thousands of com-
mon variants with very small effect sizes are part of the genetic
architecture of these disorders (Ripke et al. 2014; Sklar et al.
2011). However, to achieve sufficient statistical power these
studies require very large sample sizes, and therefore make
replication difficult (Geschwind and Flint 2015). This prob-
lem has served as a motivation for the creation of the
Psychiatric Genomics Consortium (PGC), which combines
genomic data for psychiatric disorders across many studies
to perform large scale GWAS analyses and promote rapid
progress in this area (Sullivan 2010; Sullivan et al. 2017).
The PGC is now a powerful international collaboration work-
ing to identify common genetic variations that contribute to
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psychiatric illnesses, including BD and SCZ. The largest SCZ
GWAS to date includes 36,989 cases and 113,075 controls
and has identified 125 genetic loci for SCZ (Ripke et al.
2014). Recently, findings from BDGWAS revealed 30 signif-
icant single nucleotide polymorphisms (SNPs), including pre-
viously reported risk loci such as the CACNA1C gene
(Mühleisen et al. 2014; Sklar et al. 2011; Stahl et al. 2017).
The understanding that each risk SNP may have a very
small additive effect across the whole genome became a major
driving force to shift the attention from candidate gene (Erk
et al. 2013; Paulus et al. 2014; Rasetti and Weinberger 2011)
to polygenic models of SCZ and BD (Rucker and McGuffin
2010; Dima and Breen 2015). The polygenic risk score
(PGRS) was developed by the Psychiatric Genomics
Consortium to measure aggregate genetic risk, based on
GWAS results (Purcell et al. 2009). Instead of exploring each
genetic risk variant individually, the idea is to link all genetic
markers and see how a cumulative effect gives evidence of
association with a disorder. First, effect sizes are estimated for
each single nucleotide polymorphism (SNP) that is associated
with a trait in a large training sample. Then, in an independent
replication sample, the PGRS is constructed for each individ-
ual and tested for association with the variable or trait of in-
terest (Fig. 1). The use of PGRS increases the power and
predictive accuracy of genetic analyses compared to candidate
gene studies and sheds new light on the understanding of
complex traits (Dudbridge 2013). Dudbridge showed that ad-
equate levels of prediction of complex traits may only be
approached when PGRS are estimated from very large sam-
ples and that this prediction will become more feasible as
sample sizes continue to grow.
A promising area for the application of the PGRS
method is the emerging field of research on imaging
genetics, which provides opportunities to investigate neu-
rophysiological and neuroimaging markers of genetic risk
for psychotic disorders (Bigos and Weinberger 2010;
Pezawas and Meyer-Lindenberg 2010). The main aim
of imaging genetics is to detect genetic factors that
may influence the structure and function of the brain,
and thus improve understanding of how this interaction
affects cognitive and emotional processes (Hashimoto
et al. 2015; Bogdan et al. 2017; Mufford et al. 2017).
There has also been success in finding genetic associa-
tions for sub-cortical brain volumes through ENIGMA
(Stein et al. 2012; Hibar et al. 2015, 2017) and subcor-
tical and cortical volumes through the UK Biobank
(Elliott et al. 2017). Until recently, the imaging genetics
field for SCZ and BD disorders was dominated by the
candidate gene approach, with the underlying problem
that candidate genes explain only a very small fraction
of the risk for the disorders (Farrell et al. 2015), however
interest in PGRS is growing rapidly. Neuroimaging
PGRS results are often inconsistent and there is a need
for a review on this topic to synthesize findings to date.
We aimed to systematically review studies applying
PGRS for SCZ and BD to functional magnetic resonance
imaging (fMRI) data to investigate the effects of genetic
risk on brain function.
Methods
Recommendations from the Preferred Reporting Items for
Systematic Reviews andMeta-analyses (PRISMA) guidelines
were used to perform the search strategy (Moher et al. 2015).
Selection criteria and study selection
The inclusion criteria were: (i) studies including fMRI data,
(ii) PGRS calculated from the SCZ and BD summary statistics
produced by the PGC.
All studies that did not meet inclusion criteria were exclud-
ed (Fig. 2). After inspection for duplicates, the titles and ab-
stracts of all studies were reviewed independently by three
authors (ZD, SR, DD). The final decision for inclusion or
exclusion of the publications was made based on a review of
the full texts.
Initially, our goal was to conduct a meta-analysis to inte-
grate data from the different studies. However, we could not
proceed with this because there was an insufficient number of
studies using similar fMRI paradigms for each PGRS (SCZ
and BP) and studies used different levels of fMRI analysis
(whole-brain vs region-of-interest).Fig. 1 Polygenic risk scoring pipeline
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Search strategy
To identify studies, we searched PubMed, Scopus, Web of
Science and Medline using the following terms: (Polygenic
Risk Score OR Cumulative Genetic Risk OR Polygenic
Profile) AND (neuroimaging OR fmri OR imaging) AND
(Psychosis OR Schizophrenia OR Psychotic disorders OR
Bipolar). Moreover, the references of all articles identified were
carefully searched for additional studies. We reviewed all pa-
pers published in the English language up toOctober 3rd, 2017.
Recorded variables, data extraction and analysis
The following variables were obtained from all articles includ-
ed in the systematic review: Name of the author, number of
participants, fMRI task, type of analysis (whole-brain or re-
gion-of-interest), main findings including association (posi-
tive vs negative), laterality, brain area and MNI coordinates.
After careful inspection of all relevant information, studies
were grouped by PGRS for SCZ or BD and classified accord-
ing to fMRI task. Additionally, three studies were identified that
used a PGRS score for psychosis or cross psychiatric disorder
that incorporated SCZ and BD summary genetics statistics.
Results
Identified studies
The search of the literature identified 35 records. After title
and abstract examination, 6 review articles were excluded.
Next, 29 potentially relevant studies were carefully evaluated.
Seventeen studies that did not contain fMRI data and/or PGRS
calculated for SCZ or BD were excluded. One study (Walton
et al. 2013) did calculate PGRS SCZ not using PGC summary
data but was excluded from the systematic review because the
same participants with the same fMRI task were tested with
PGRS SCZ scores from the PGC in another study that we
have included in our review (Walton et al. 2014). These two
studies showed similar results. Thus, 12 papers were included
in the systematic review (Fig. 1).
Studies were classified according to PGRS calculated for
SCZ, BD or psychosis and cross psychiatric disorders. The
studies included in the systematic review describe seven stud-
ies with PGRS for SCZ (Table 1), four studies with PGRS for
BD (Table 2), one study with PGRS for psychosis and two
studies with PGRS using Cross Disorder summary statistics
(Table 3). Eleven studies used task fMRI (Cosgrove et al.
2017; Dima et al. 2016; Erk et al. 2017; Kauppi et al. 2015;
Lancaster et al. 2016a, b; Rampino et al. 2017; Tesli et al.
2015; Walton et al. 2014; Whalley et al. 2012, 2015), and
one used resting state fMRI data (Wang et al. 2017).
Polygenic risk score for schizophrenia (PGRS-SCZ)
Of the 7 studies using PGRS for SCZ, six tested associations
between PGRS and different fMRI tasks (four working mem-
ory, two emotional processing, one episodic memory, one the-
ory of mind, one reward processing, one attention control
processing, one probabilistic decision making) (Cosgrove
et al. 2017; Erk et al. 2017; Kauppi et al. 2015; Lancaster
et al. 2016a; Rampino et al. 2017; Walton et al. 2014), and
one study reported results between PGRS-SCZ and resting
Fig. 2 Study selection process
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state fMRI data (Wang et al. 2017). See Table 1 for details of
these studies.
Of the four studies reporting results of working memory
(WM), Kauppi et al. (2015) used a WM N-back task with a
block design and 3 conditions (0-back, 2-back, and baseline)
in 63 SCZ patients and 118 healthy controls, matched for
education and IQ (mean > 100). Whole brain analysis was
performed to explore whether increased genetic risk for SCZ
would be associated with altered brain activation during WM
processing. Ten PGRS-SCZ were initially computed based on
different p-value thresholds for SNPs inclusion, however the
threshold of 0.05 was chosen since it explained the most var-
iance in case-control data. The PGRS-SCZ was negatively
associated with brain activation during the 2-back >0-back
contrast in the right inferior frontal gyrus, right middle/
superior prefrontal cortex, and right middle temporal gyrus.
The 2-back > baseline contrast revealed a negative correlation
between PGRS and brain activation in the anterior cingulate
cortex, right inferior frontal gyrus/insula, and in the bilateral
postcentral gyrus. To correct for multiple comparisons the
authors performed cluster-level correction with z-value >2.3
and a corrected cluster significance threshold of P = .05.
A positive association between PGRS calculated for SCZ
and whole-brain neural activity during a WM block task was
found in the study of Walton et al. (2014) in a sample of 92
SCZ patients and 114 healthy controls, matched for age, gen-
der and parental education. For replication purposes, two in-
dependent discovery samples were used to calculate PGRS
scores; from the International SCZ Consortium (ISC)
(Purcell et al. 2009) and from the Psychiatric Genomics
Consortium (PGC) (Ripke et al. 2011). Initially, the case-
control dataset from the ISC were used to calculate PRGS
using 7 different statistical thresholds (P < 0.01, P < 0.05,
P < 0.1, P < 0.2, P < 0.3, P < 0.4, and P < 0.5). For a replica-
tion analysis, PGRS were computed using the PGC dataset
following the method of Purcell and colleagues (P < 0.01)
(Purcell et al. 2009). The Sternberg Item Recognition
Paradigm (SIRP) was administered during six blocks com-
posed of 1 (load 1), 3 (load 3), or 5 (load 5) digits. A positive
relationship between PGRSISC (P < .01) and neural activity was
found in the left dorsolateral prefrontal cortex (DLPFC) and
left ventrolateral prefrontal cortex (VLPFC). Additionally, a
positive association between neural activity in the anterior
cingulate cortex (ACC) and bilateral DLPFC and PGRS
PGC (P < .01) was reported. All clusters were corrected with z-
value >2.3 and Bonferroni corrected with a P value of .007
(.05/7). PGRSISC(P < .01) accounted for 4.3% of the total var-
iance R2 = 0.048, P = .002 at the most activated DLPFC loca-
tion (x, y, z: −6, 38, 48). A positive association was also found
between the DLPFC and the PGRS-SCZ in the Walton et al.
2013 paper where for the same pool of participants PGRS-
SCZ were calculated from 41 SNPs in 34 genes (SNPs were
identified from a meta-analysis of genetic studies on
schizophrenia available at www.schizophreniaresearchforum.
org; February 24, 2010).
The study byCosgrove et al. (2017) used a spatialWM task
as well as a face processing task to identify association be-
tween cognitive performance and PGRS of 1016 genes whose
expression is altered by miR-137 manipulation (Hill et al.
2014). It has been known that variants at microRNA-137
(MIR137) influence the expression on a set of genes, and
some of them are independently associated with SCZ
(Collins et al. 2014). 831 of these genes could be unambigu-
ously mapped to the autosomes and this gene set was used to
generate polygene scores. They then cross-referenced these
genes with unweighted P-values from the PGC2 GWAS
(Ripke et al. 2014) and a weighted polygene score was created
for each participant. For the spatial block WM task three dif-
ferent conditions were used (baseline-, 1- and 3- dot task), and
two contrasts investigated: spatial WM (1 dot and 3 dots vs
baseline), and high spatial WM load (3 dots vs 1 dot).
Analysis was performed at three different thresholds (P =
10−5, P = 0.05 and P = 0.5). Results were examined at a P <
0.001 (uncorrected) level and clusters were considered statis-
tically significant at a P < 0.05 level, family-wise error (FWE)
corrected for multiple comparisons across the whole brain at
the cluster level. Results showed that higher PGRS-SCZ (P =
10−5) of the miR-137 pathway were significantly associated
with increased neural activation in two clusters with increas-
ing spatial WM load (3 dots vs 1 dot contrast). This hyper-
activation was found in the right inferior occipital gyrus and
right middle temporal gyrus. Cosgrove et al. (2017) also in-
vestigated associations between the PGRS-SCZ and fMRI
activity during an emotional processing task including angry
and neutral faces. For this task, no association was found
significant.
Erk et al. (2017) tested five neuroimaging cognitive para-
digms of the Research Domain Criteria (RDoC). PGRS-SCZ
was calculated from summary data from the PGC (Ripke et al.
2014) to assess its effect on predefined regions of interest
(ROIs) during WM, reward processing, episodic memory, so-
cial cognition and emotion processing tasks. Results for
PGRS were significant only for the episodic memory task
and social cognition (a Theory of Mind –ToM- task) at
PFWE (ROI) < 0.05, but would not withstand multiple compar-
ison correction for the total number of ROI analyses per-
formed across all tasks (P < 0.0025; 0.05/20 ROI analyses).
For episodic memory 287 healthy individuals with no family
history of SCZ and 195 healthy individuals with at least one
first-degree relative affected by SCZ completed an associative
episodic memory task requiring encoding, recall and recogni-
tion of face-profession pairs (a face linked to an occupation;
memory>control). A significant negative correlation was
found for pregenual anterior cingulate cortex activation and
PGRS during episodic memory recognition. The association
between ToM (mentalizing) processing and PGRS was tested
Brain Imaging and Behavior
in 281 healthy individuals without family history and 214
participants with family history of SCZ. A ROI analysis
yielded that PGRS-SCZ predicted high activity in the posteri-
or cingulate cortex and the precuneus during the ToM task
(mentalizing>control), at PFWE (ROI) < 0.05, but would not
withstand multiple comparison correction for the total number
of ROI analyses performed across all tasks (P < 0.0025; 0.05/
20 ROI analyses).
Lancaster et al. (2016a) investigated the association be-
tween PGRS-SCZ and decision-making processing in 83
healthy controls with no history of psychiatric or neurolog-
ical disorder and IQ score above 70. PGRS for SCZ was
calculated at P < 0.5. Whole brain and ROI analyses were
performed against choice (shift>stay) and outcome
(reward>punishment) behavior. In the whole-brain analy-
sis, a negative correlation was observed between activation
of the right frontal pole and PGRS-SCZ in choice (PFWE-
WHOLEBRAIN corrected). In the ROI analysis of the choice
processing an additional negative association was found
between PGRS-SCZ and the left ventral striatum (PFWE-
ROI corrected). No correlation was found in the outcome
condition.
The study by Rampino et al. (2017) used a Visual Attention
Control (VAS) task to test the association between PGRS-SCZ
as well as PGRS-SCZ-Glu and brain activity in two indepen-
dent samples of healthy participants consisting of 151 and 51
subjects respectively. Both the discovery and replication sam-
ples had no history of psychiatric or neurological conditions,
of drug/alcohol abuse, or of trauma/loss of consciousness.
PGRS-SCZ was calculated following the method reported
by Purcell et al. (2009) with a threshold of P = 10−8.
Subsequently, SNPs associated with glutamatergic neuro-
transmission pathway were detected along previously selected
SNPs and PGRS-SCZGlu were calculated. The VAS task in-
cluded three different load conditions with increasing level of
attention. Results were thresholded at P < .05, small volume
FWE corrected, by computing a mask of key regions of atten-
tion control processing. A significant positive correlation was
found between the left superior frontal gyrus and
PGRS-SCZGlu in both groups. No significant correlations
were identified between PRS-SCZ and brain activity during
the VAC task.
Lastly, Wang et al. (2017) inspected the effect of PGRS-
SCZ on functional connectivity on fMRI resting state data on
two independent groups of healthy participants, consisting of
360 and 323 individuals respectively. Analysis was based on
the PGRS calculated at P < 0.05. Functional connectivity
maps for each subject were calculated by computing correla-
tion coefficients between time series in the insula (ROI bilat-
eral) and time series from all other graymatter voxels through-
out the brain. Age, sex, and the three top principle components
were included in the regressionmodel as covariates. Statistical
maps were generated at a voxel-level of P < 0.05 and cluster
size >90 voxels to reach a cluster level significance of alpha
<0.05 (for multiple corrections the Alphasim algorithm was
used). Altered functional connectivity was found with the bi-
lateral insula and the left angular gyrus and the left dorsolat-
eral prefrontal cortex associated with the PGRS-SCZ.
Polygenic risk score for bipolar disorder (PGRS-BP)
Of the four studies investigating the PGRS for BP, three ana-
lyzed associations between PGRS-BD and different fMRI
tasks (one WM, two emotional face processing, one verbal
fluency task) (Dima et al. 2016; Tesli et al. 2015; Whalley
et al. 2012). Additionally, one study reported results using
PGRS-BP and resting-state fMRI data (Wang et al. 2017).
Details for these studies are presented in Table 2.
Dima et al. (2016) tested the PGRS-BD effect on WM
and emotional face recognition using fMRI data in 41
affected patients, 25 healthy first degree relatives and 46
healthy controls. PGRS for BD were based on BD sum-
mary statistics from the latest PGC GWAS of BD (Cross-
Disorder Group of the Psychiatric Genomics Consortium
2013). PGRS-BD scores were derived using seven statis-
tical thresholds with P-values <0.001, 0.05, 0.1, 0.2, 0.3,
0.4 and 0.5. Although the effect of group was significant
at all thresholds, the highest difference (F = 5.94, p =
0.004) was found for the PGR-BD score with P < 0.1, thus
this threshold was chosen for further analysis. A negative
association between PGRS-BD and emotional face recog-
nition was found in the visual cortex, and a positive asso-
ciation in the ventromedial prefrontal cortex for the WM
task (P < 0.05 FWE correction and cluster size, k > 20).
In the study by Tesli et al. (2015), 85 bipolar patients and
121 healthy controls participated in an fMRI emotional faces
matching paradigm with four different conditions: negative
faces > shapes, positive faces > shapes, faces > shapes, and
positive > negative faces. A total of ten PGRS were computed
for BD (calculated using summary statistics by Sklar et al.
2011) based on different P-value thresholds (P = 1, 0.5, 0.4,
0.3, 0.2, 0.1, 0.05, 0.01, 0.001, and 0.0001). The PGRS
explaining most of the variance patients vs controls was the
one with a P-value threshold of 0.05. A positive correlation
between PGRS-BD and brain activation was found in the right
inferior frontal gyrus (negative > shapes), and a negative as-
sociation was found in the right postcentral gyrus (negative >
positive) across the whole group, z-threshold>2.3 as cluster-
level correction although neither result survived a Bonferroni
correction.
Whalley et al. (2012) investigated the relationship between
PGRS-BD (calculated using summary statistics by Sklar et al.
2011) and brain activation during an fMRI verbal fluency task
(the Hayling Sentence Completion Test) in 87 individuals
with high risk for BD and 71 healthy controls. In total, 4
PGRS-BD were computed (P = 0.001, P = 0.01, P = 0.05,
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P = 0.1); the P = 0.5 was chosen for subsequent analysis as
this level most efficiently discriminated individuals with and
without BD. The whole brain analysis revealed a significant
positive association between PGRS-BD and activation in the
anterior cingulate cortex and in the right amygdala with in-
creasing task difficulty (significant at a cluster level of P <
0.05, corrected for multiple comparisons).
The study by Wang et al. (2017) tested the PGRS-BP (cal-
culated from the Cross-Disorder Group of the Psychiatric
Genomics Consortium 2013 at P < 0.05) on functional con-
nectivity of resting state fMRI data. A significant positive
relationship was found between PGRS-BP and functional
connectivity between the insula (ROI insula) and the bilateral
cuneus, precuneus and posterior cingulate. A negative rela-
tionship was identified for the PGRS-BD and functional con-
nectivity between the bilateral midbrains and the bilateral
insula (cluster level significance of alpha <0.05). Age, sex,
and the three top principle components were included in the
regression model as covariates.
Cross-disorder and psychosis polygenic risk scores
Investigating PGRSs for cross-disorder psychopathology
(PGRS-CROSS) is justified since evidence has revealed
shared genetic links across five common psychiatric illnesses
(autism, attention deficit-hyperactivity disorder, BD, major
depressive disorder and SCZ) based on accumulated effects
of many common variants (Cross-Disorder Group of the
Psychiatric Genomics Consortium 2013). Two studies exam-
ined the influence of PGRS-CROSS (Wang et al. 2017;
Whalley et al. 2015) and one study the influence of PGRS
for psychosis (Lancaster et al. 2016b) on brain function and
were included in the present systematic review (Table 3).
Studies examining PGRS for psychosis utilize the fact that
psychotic disorders share considerable genetic variance
(Ruderfer et al. 2014), have substantial overlap in the clinical
phenotype (Craddock et al. 2009) and have shown brain acti-
vation changes in similar frontal networks (Birur et al. 2017).
This stream of research tests the hypothesis that SCZ and
BD lie on a transdiagnostic psychosis spectrum with over-
lapping affective and non-affective psychotic symptoms
(Reininghaus et al. 2016).
In the Lancaster et al. (2016b) study, PGRS for psychosis
was calculated for healthy adolescents using PGC summary
statistics for SCZ and BD (Ruderfer et al. 2014). Just over
1500 participants performed an fMRI task evaluating reward
processing during two conditions; reward anticipation and re-
ward receipt. PGRS scores were derived using four thresholds
with P-values <0.01, 0.05, 0.1 and 0.5. Only the association
with the ventral striatum was examined, with age, sex, testing
site, IQ and the first five principle components (from the
variance-standardized relationship matrix of the linkage dis-
equilibrium–pruned genotypes) were included in the
regression models. Analysis revealed a significant positive
association between PGRS for psychosis and activation in
the left ventral striatum in anticipation for all psychosis
PGRS thresholds and in reward receipt for PGRS thresholds,
P < 0.01 and 0.5. The results survived multiple testing using
FWE correction (P < .05). Additionally, a post-hoc analysis
investigating the PGRS for BD and SCZ separately found that
activity in the ventral striatum during reward processing was
influenced by both scores.
Whalley et al. (2015) tested the effect of the PGRS-CROSS
(Cross-Disorder Group of the Psychiatric Genomics
Consortium 2013; significance level of P = 0.05) in a group
of 82 people with family risk for BD and 57 healthy controls
during an fMRI verbal fluency task (the Hayling Sentence
Completion Test). There were no significant associations
across the whole sample, but a significant interaction was
found between PGRS-CROSS and group status in the frontal
cortex encompassing the left inferior frontal gyrus, precentral
and postcentral gyri. This interaction was driven by healthy
controls, and not by individuals at high risk of bipolar disor-
der. Although, statistical maps were thresholded at a level of
P < 0.001 (uncorrected), regions reported as significant sur-
vived at a cluster level of P < 0.05, corrected for multiple
comparisons. Further analyses revealed that the PGRS con-
tributing the greatest effect was specific to SCZ.
Wang et al. (2017) investigated the effect of PGRS-CROSS
on functional connectivity in fMRI resting state data. GWAS
results from the PGC (Cross-Disorder Group of the
Psychiatric Genomics Consortium 2013) were used as train-
ing data to generate PRGS-CROSS. In two independent
datasets, with 360 and 323 healthy participants respectively,
functional connectivity maps for each subject were calculated
by computing correlation coefficients between time series in
the ROI (bilateral insula) and time series from all other gray
matter voxels throughout the brain. A negative relationship
was identified between the PGRS-CROSS and the coupling
of the left supplementary motor and left superior temporal
gyrus with bilateral insula.
Discussion
This is the first systematic review to examine the effects of
PGRS-SCZ, PGRS-BD, PGRS-CROSS and PGRS for psy-
chosis on brain function and connectivity using fMRI data.
The diversity of designs, tasks, and types of measurement
precludes us from performing a meta-analysis, but allows us
to summarize the findings and draw some conclusions.
PGRS and memory
The results of four studies focusing on WM-related brain ac-
tivation and the effect of PGRS-SCZ on it demonstrated that:
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(a) healthy individuals with high PGRS-SCZ showed in-
creased cortical activation in the right inferior occipital gyrus
and the right middle temporal gyrus (Cosgrove et al. 2017),
(b) there is a negative relationship between PGRS-SCZ and
inferior/middle prefrontal cortex and middle temporal gyrus
activation (Kauppi et al. 2015), (c) there is a positive associ-
ation between PGRS-SCZ andWM-related brain activation in
the left dorsolateral and ventrolateral prefrontal cortex
(Walton et al. 2014) and (d) no association was found in the
Erk et al. (2017) study between WM brain activation and
PGRS-SCZ.
The hyper-activation found in the right inferior occipital
gyrus and right middle temporal gyrus in individuals with
high miR-137 PGRS might reflect relative cortical inefficien-
cy which is associated with schizophrenia (Cosgrove et al.
2017). Although Kauppi et al. (2015) and Walton et al.
(2014) used the same method to calculate PGRS-SCZ to test
WM-related brain activation, the results are contradictory
showing both frontal hyper- and hypo-activation during WM
processing. One possible source of difference between results
of these studies is that similar but not identical WM tasks were
used as well as the contrasts tested against the PGRS. The
Sternberg Item Recognition Paradigm used by Walton et al.
(2014) emphasizes the maintenance of information, while the
N-back WM task used by Kauppi et al. (2015) accentuates
updating processes. Another reason for the contradictory find-
ings could be brain activation differences between high and
lowWM load conditions in individuals with high PGRS-SCZ.
There might be a positive relationship between PGRS-SCZ
and brain activation at low WM loads reflecting cognitive
effort, while hypo-activation of frontal lobe regions at more
demanding tasks could be explained due to neural inefficiency
and decreased flexibility in recruiting neural resources in re-
sponse to task difficulty (Kauppi et al. 2015; Kim et al. 2010;
Potkin et al. 2009). It has also been argued that there is a
complex pattern of hypo- and hyperactivation across the brain
in response to WM processing in SCZ, and that rather than
looking at individual brain regions, the entire network of ac-
tivation and co-activation needs to be taken into account
(Glahn et al. 2005). This might also be true for individuals
with high PGRS for SCZ, reflected in the differences in find-
ings reported across studies reviewed here, and speaking to
the need for multivariate analyses methods in future studies.
When it comes toWMprocessing in BP, Dima et al. (2016)
found hyper-activation of the frontal lobe (particularly the
ventromedial prefrontal cortex) in individuals with high
PGRS for BD, although the areas of abnormal activation dif-
fered from studies of the PGRS for SCZ. The ventromedial
prefrontal cortex integrates information which is represented
in separate parts of the limbic system (the hippocampus, the
amygdala, and the ventral striatum), and its function is re-
duced during cognitive tasks performance (Nieuwenhuis and
Takashima 2011). However, people with high genetic risk for
BD failed to deactivate this area during a memory task and
instead demonstrated hyper-activation (Dima et al. 2016).
Investigating the relationship between PGRS-SCZ and ep-
isodic memory processing, Erk et al. (2017) found that the
PGRS-SCZ is associated with hypo-activation of the
pregenual anterior cingulate cortex during this task. Many
studies have shown evidence of episodic memory dysfunction
in SCZ (Leavitt and Goldberg 2009; Ranganath et al. 2008),
and this has been associated with prefrontal activation deficits
(Achim and Lepage 2005). This may point to the reason why
individuals with high PGRS for SCZ demonstrated
hypoactivation in left anterior cingulate cortex during episodic
memory recognition in the study by Erk et al. (2017).
PGRS and emotional processing
BD is characterized by disturbances in emotional processing
and regulation (Green et al. 2007; Townsend and Altshuler
2012), that are likely influenced by genetic factors (Brotman
et al. 2008; Lelli-Chiesa et al. 2011; Radua et al. 2012).
Altered brain activation during emotional processing in rela-
tion to PGRS-BDwere explored in two studies reviewed here.
Functional abnormalities were found (a) in the left visual as-
sociation cortex during negative vs neutral face recognition
(Dima et al. 2016), and (b) in the right inferior frontal gyrus
during negative faces vs shapes and in the right postcentral
gyrus during negative vs positive face processing (Tesli et al.
2015). These findings are in line with the hypothesis that BD
is caused by a combination of interacting genetic factors that
are associated with abnormalities of emotional processing.
Erk et al. (2017) and Cosgrove et al. (2017) both investi-
gated links between the PGRS for SCZ and emotional pro-
cessing, but neither found evidence of an association.
Emotional processing has been found to be impaired in pa-
tients with SCZ (Bora and Pantelis 2016; Edwards et al. 2002;
Marwick and Hall 2008) as well as in unaffected relatives of
SCZ patients (Bediou et al. 2007; Lavoie et al. 2013; Park
et al. 2016), suggesting a genetic component to this distur-
bance. The lack of significant associations between genetic
risk for SCZ and brain activation during emotional processing
in the two studies reviewed here (Cosgrove et al. 2017; Erk
et al. 2017) could be because the PGRS-SCZ is picking up
primarily working memory disturbances, but as discovery
sample sizes continue to grow and the PGRS-SCZ becomes
more sensitive, emotional areas might be identified too.
Alternatively, associations between emotional brain activation
and genetic risk for SCZ might be driven by genetic markers
not captured by the current PGRS, such are rare variants.
PGRS and other cognitive processes
Investigating the relationship between PGRS-SCZ and ToM
processing Erk et al. (2017) found a positive correlation
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between PGRS-SCZ and activity in the posterior cingulate
cortex and the precuneus complex during mentalizing pro-
cessing. Mentalizing is an important social cognition function
that refers to the ability to understand one’s own and other
peoples’ mental states. There is evidence that people with
SCZ are impaired in mentalizing and ToM performance
(Bora et al. 2009) and previous work has linked genetic risk
alleles associated with schizophrenia (in the ZNF804A gene)
with decreasing activity of the left temporo-parietal junction,
dorsomedial prefrontal cortex and the posterior cingulate cor-
tex, during ToM processing in healthy individuals (Mohnke
et al. 2014; Walter et al. 2011). Furthermore, there is evidence
that a number of genetic markers relating to ToM impairment
are associated not only with schizophrenia, but across several
psychiatric conditions (Martin et al. 2014). It would therefore
be useful for future research to address the genetic associa-
tions with ToM processing across diagnostic boundaries.
Lancaster et al. (2016a) investigated the association be-
tween PGRS-SCZ and brain activity during decision making
processing. They found a negative association between PGR-
SCZ and right frontal pole and the left ventral striatum activa-
tion. Hypo-activation of the right frontal pole has previously
been associated with cognitive deficit symptoms of SCZ
(Orellana and Slachevsky 2013). The current results demon-
strate a negative relationship between PGRS-SCZ and
frontostriatal activation and may reflect cumulative genetic
susceptibility for SCZ affecting parameters of probabilistic
learning. Additionally, frontal hypoactivation may be linked
with poor motivation associated with negative symptoms of
SCZ and these changes in neural networks may reflect genetic
risk for this disorder (Lancaster et al. 2016a).
A recent meta-analysis of 23 studies revealed that psycho-
sis is associated with hypoactivation of the ventral striatum
during reward anticipation in adults (Radua et al. 2015).
However, in a large sample of healthy adolescents,
Lancaster et al. (2016b) found that increased polygenetic risk
for psychosis is associated with hyper-activation of this brain
region during reward processing. This difference in findings
could be – as suggested by Lancaster et al. (2016b) – due to
the difference in age between the samples, and genetic risk for
psychosis might have different effects on brain function across
the lifespan. It has, for example, been shown that younger
adolescent offspring of patients with schizophrenia show hy-
per-activation, whereas older adolescent offspring show hypo-
activation, of the ventral striatum during reward processing
(Vink et al. 2016). Recent studies have demonstrated the sig-
nificant role of methylation quantitative trait loci in brain de-
velopment and SCZ (Hannon et al. 2016; Jaffe et al. 2016) as
well as significant associations between methylation and gray
matter and SCZ diagnosis in both saliva and blood tissues (Lin
et al. 2018). Epigenetics do play a role and future studies
should combine epigenomic/genomic analyses in schizophre-
nia cases to decipher how genetic risks influence structural
and functional brain components through epigenetic
mediation.
Several neuroimaging studies have identified modification
in prefrontal cortex processing of attention stimuli in patients
with schizophrenia (Blasi et al. 2010; Delawalla et al. 2008).
There is evidence that variation in attention is partially asso-
ciated to glutamatergic neurotransmission pathways (Craven
et al. 2014). Investigating the relationship between polygenic
risk related to glutamatergic neurotransmission and attention
control processing, Rampino et al. (2017) found a positive
association between PGRS-SCZGlu and prefrontal cortex ac-
tivity during the VAC sustained attention task. The results
show that greater engagement of prefrontal resources leads
to lower performance efficiency in people with high genetic
risk for schizophrenia during VAC task. Additionally, no re-
lationship between PGRS-SCZ and fMRI activity was found
suggesting that pathway specific PGRS may be a more useful
tool in detecting genes-brain-behavior relationships.
In two studies, Whalley and colleagues investigated asso-
ciations between brain activation during a language-based ex-
ecutive processing task and the PGRS-BP (Whalley et al.
2012) and the cross-disorder PGRS (Whalley et al. 2015).
They found a significant positive association between
PGRS-BD and activation of the anterior cingulate cortex and
amygdala (Whalley et al. 2012). The existing literature on
imaging studies of BD provides evidence for the involvement
of these brain regions (Arnone et al. 2009; Chen et al. 2011;
Strakowski et al. 2012) and results from the study byWhalley
et al. (2012) indicate that the effect of genetic load for BD on
brain function affects task-related recruitment of these brain
regions. There was also a positive association between the
cross-disorder PGRS and brain activation during executive
functioning in frontal regions, driven by genetic risk for
SCZ (Whalley et al. 2015). Again, this is consistent with pre-
vious research implicating altered frontal activation in SCZ
during executive function tasks (Costafreda et al. 2011;
Sutcliffe et al. 2016).
Lastly, Wang et al. (2017) explored the relationship be-
tween resting state functional connectivity and cross-
disorder PGRS as well as PGRS for specific disorders in
healthy individuals. Results showed that altered bilateral insu-
lar functional connectivity patterns correlated with increased
cross-disorder as well as PGRS- SCZ and BP, indicating that
such functional connectivity changes might be genetically
modulated (Wang et al. 2017). The insula is a key node in
the salience network that is important for detecting behavior-
ally relevant stimuli, and altered processing of the insula is
implicated in a range of major psychiatric illnesses including
SCZ and BP (Uddin 2014; White et al. 2010). Altered func-
tional connectivity between the insula and the posterior cin-
gulate cortex and the precuneus was associated with the PGRS
for BP, and altered insula – angular gyrus connectivity was
associated with the PGRS for SCZ (Wang et al. 2017). These
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regions are part of the default mode network (mainly active
whilst not performing a cognitive task), which has previously
been implicated in these disorders (Öngür et al. 2010). The
PGRS for SCZ was furthermore associated with altered con-
nectivity between the insula and the dorsolateral prefrontal
cortex (Wang et al. 2017), which is a hub of the central-
executive network that show increased activity during cogni-
tively demanding tasks (Sridharan et al. 2008). It is thought
that the salience network plays an important role in switching
between the default-mode and the central-executive networks
(Menon and Uddin 2010; Sridharan et al. 2008) and results
reviewed here might indicate that a dysfunction of this
switching mechanism is mediated by genetic risk for psychi-
atric illnesses including SCZ and BP.
Limitations, future directions and conclusions
The conclusions from this systematic review should be con-
sidered in the light of the following limitations in the literature.
First, most studies used small sample sizes – with the notable
exception of Lancaster et al. (2016b) including over 1500
individuals – limiting the possibility of drawing any strong
conclusions from findings (for more detail on appropriate
sample sizes see Dudbridge 2013; Visscher et al. 2017).
Secondly, there are significant differences in methodology,
making it difficult to compare findings across studies. This
involves (i) the inclusion of different combinations of healthy
individuals, people at high genetic risk for psychiatric disor-
ders, and patients themselves, (ii) important differences in
fMRI analyses methods, with some restricting their analyses
to regional effects using a ROI approach, whereas others use
whole-brain analyses, (iii) the use of different P-value thresh-
olds for the calculations of PGRS and (iv) only two studies
(Cosgrove et al. 2017; Rampino et al. 2017) utilize the PGC
SCZ summary statistics by considering a specific biological
pathway (themiR-137 pathway; glutamatergic neurotransmis-
sion pathway). Since it is unlikely that the combined effect of
all genetic markers for a disorder should influence a single
neural circuit, exploring biological pathways when
conducting these types of analyses might result in more infor-
mative findings (Hall et al. 2015). Lastly, most studies did not
investigate possible confounding factors that might influence
results, such as environmental risk factors.
To limit the impact of these issues and for this field of
research to move forward and produce more conclusive find-
ings, we propose the following recommendations: 1) an in-
crease in the sample sizes of studies, through collaborations
and the development of consortia, 2) replication of existing
findings, 3) the development of optimum PGRS thresholding
approaches (e.g. choosing the PGRS that best predicts the
target data phenotype, to accommodate the fact that the dis-
covery summary statistics GWAS data can vary by p-
threshold depending on heritability, sample size or by
applying high-resolution PGRS detection – Euesden et al.
2015), 4) standardization of fMRI paradigms, 5) collecting a
resting state fMRI which is not confounded by differences in
performance as part of acquisition pipelines, 6) correlating
brain activity from fMRI tasks with a standardized psycho-
metric test battery collected outside of the scanner that are
potentially scalable online to large cohorts common in genetic
studies, 7) the use of data reduction and multivariate machine
learning methods to investigate networks of brain co-
activation rather than focusing on individual regions, 8) stud-
ies to explore PGRS for specific biological pathways in imag-
ing studies to elucidate neurobiological mechanisms in order
to further the understanding of underlying mechanisms and to
develop new hypotheses and 9) reporting of effect sizes to
facilitate comparison across studies.
Furthermore, limitation (ii) regarding differences in fMRI
analyses methods, is a challenge faced not only by the imag-
ing genetics field but by the wider fMRI neuroimaging
community and has recently been commented by Poldrack
et al. (2017) that have proposed some excellent solutions.
Briefly, the authors propose (a) planning (sample size should
be pre-determined using power analysis and the analysis plan
pre-registered), (b) implementation (codes for data collection
and analysis, and data sets and results should be placed in a
repository), (c) validation (exploratory results should be vali-
dated against an independent validation data set) and (d) dis-
semination (results should be marked as either hypothesis-
driven, with a link to pre-registration, or exploratory. All anal-
yses performed on the data, significant, useful or not should be
reported) (Poldrack et al. 2017).
In the last years, advances have been made in large-scale
neuroimaging genetics studies, such as the innovative
Alzheimer’s Disease Neuroimaging Initiative (ADNI;
Weiner et al. 2010) and the ENIGMA consortium which took
the novel approach by combining existing genomic and im-
aging data from around the globe (Bearden and Thompson
2017). Current big data initiatives, like the UK Biobank a
prospective epidemiological resource gathering extensive
questionnaires, physical measures, cognitive measures, neuro-
imaging and genotyping data in a cohort of 500,000 partici-
pants has minimized variations in scanner, acquisition and
analytical approaches (Sudlow et al. 2015) and holds great
promise for the future.
In conclusion, the existing literature has important method-
ological limitations, but has nevertheless provided some pre-
liminary findings regarding the relationships between brain
activation and cumulative genetic risk for SCZ and BD.
Overall, it suggests that the effect of PGRS for SCZ or BD
is not localized to a single region or neuronal pathway, but
instead influence task-dependent brain activation of whole
brain networks. The current findings do however support the
notion that the PGRS methodology could be informative in
terms of identifying patterns of neural activation that could
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mediate vulnerability to SCZ or BD rather than symptom ex-
pression. Future imaging genetics studies with large samples
would be uniquely informative in mapping the spatial distri-
bution of the genetic risk to psychiatric disorders on brain
processes during various cognitive tasks and may lead to the
discovery of biological pathways that may be crucial in me-
diating the link between genetic factors and alterations in brain
networks in this disorder. As interest in imaging genetics re-
search continues to grow, multimodal neuroimaging and
PGRS approaches are likely to become major tools in the
investigation of the pathophysiology of psychiatric disorders.
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